自2008年起，医院先后被省有关部门批准为山东省眼科临床专业质量控制中心、山东省眼科医学临床中心、山东省角膜病防治与功能重建技术工程中心；国家住院医师规范化培训基地，亚洲角膜病协会（Asia Cornea Society）国际住院医师培训单位。
副 院 长：高 华
副 院 长：王 婷
Shandong Eye Hospital was founded in 2004 by Professor Lixin XIE, the only academician of the Chinese Academy of Engineering in ophthalmology, which is an important measure taken by Shandong Provincial Committee and Provincial Government to enlarge and strengthen the “Big Ophthalmology in Shandong” and to increase the Academician Effect, and also a significant step of Shandong Eye Institute to “grow bigger and stronger”. Shandong Eye Hospital is one of the largest state-owned provincial-level Third-grade Class-A specialized eye hospital in China that integrates medical treatment, teaching, scientific research and blindness prevention.
Led by the academician, our hospital has advantages of talents, technology and scientific research, which is prominent in the country and leading in the province. Our hospital was founded by the academician; an expert of our hospital is the vice chairman of the Asia Cornea Society, a member of the Standing Committee of the Ophthalmological Society of Chinese Medical Association and the leader of the Corneal Disease Group. The only specially-invited expert of leading medical talents in Shandong Province also work in our hospital.
The hospital is a leading unit in keratopathy diagnosis, treatment and research in China, and one of the most important corneal transplantation centers in China. Our hospital has outstanding specialists, technical advantages and innovative ability in the treatment of various eye burns, corneal infections, keratoconus, femtosecond laser-assisted corneal transplantation, endothelial transplantation and many other difficult keratopathies. Our hospital is the only unit in China that has published a series of monographs of corneal diseases (a total of 5 monographs, more than 5 million words). It is also an important base for the diagnosis and treatment of difficult cataracts, pediatric cataracts and retinal fundus oculi diseases in China. Our hospital is one of the few hospitals in China that can complete the major surgery of eyes (corneal transplantation combined with vitrectomy for the treatment of complex ocular trauma and other anterior and posterior segment combined surgeries).
Experts of our hospital have published 12 papers in Ophthalmology, the number one academic journal in ophthalmology in the world, ranking first in China. With many innovations in corneal and ocular surface surgeries, our hospital has won two Second Prize in the National Science and Technology Progress Award, being the only one in Shandong province that has won two Second Prize in the National Science and Technology Progress Award in the past 20 years.
Since 2008, our hospital has been approved by the provincial authorities as Shandong Provincial Quality Control Center for Clinical Ophthalmology, Shandong Provincial Medical Center for Clinical Ophthalmology, Shandong Provincial Technological Engineering Center for Corneal Disease Prevention and Functional Reconstruction, National Standardized Training Base for Resident Physician, International Resident Physician Training Unit of Asia Cornea Society.
Facilities and Equipment
Our hospital now has 30,000 square meters for business purpose and 200 opening beds. Shandong Corneal Disease Prevention and Treatment Research Center, the largest corneal disease prevention and treatment center of Asia, built with an investment of 200 million yuan, has been put into use.
Over the past 10 years, our hospital has introduced more than 500 sets of internationally advanced ophthalmic exam, treatment and surgical equipment from the United States, Germany and Japan. An annual investment of 10 million yuan is used for the renewal and maintenance of equipment and facilities. The hardware level of medical services has always been at the leading level in the country and at the advanced level internationally.
Under the guidance of Academician Lixin XIE, our hospital has nearly 200 employees, more than 150 of whom are medical professionals. A team of mid-level and high-level professionals represented by the leading medical talents in Shandong Province, the young and middle-aged experts with outstanding contributions in Shandong Province and the experts of Taishan Scholar Program of Shandong Province has been built. There are more than 70 physicians in total and 15 of them have senior professional titles. More than 30% of our doctors have foreign study experience and doctoral degree, and over 70% of our doctors have master's degree or above. The hospital has always attached great importance to the cultivation and introduction of high-end talents. In the past five years, our hospital has introduced more than 10 professionals graduated from well-known medical colleges and universities in China with doctoral degree.
With the guidance of Academician Lixin XIE, the hospital has also formed a young and dynamic team of clinical professionals with Professor Weiyun SHI (national industry leader) as the leader, provincial-level leading experts as the backbone, young experts with doctoral degree as the main body and a group of young professionals with master’s degree as the foundation. More than 10 doctors in our hospital are qualified doctoral supervisor or master’s supervisor of Shandong University, Qingdao University or Jinan University, forming a team of teachers full of vigor and vitality. The teams are the solid foundations for the long-term development of our hospital.
Our hospital has many clinical departments, including corneal disease, cataract, fundus disease (internal and external), glaucoma, eye muscle refraction, oculoplastic & orbital surgery, corneal refraction, optometry (including providing optometry services of orthokeratology). Our well-known expert clinics, expert clinics, doctoral clinics and professional clinics can meet the needs of different patients. Our qualified doctors can diagnose and treat a variety of common and difficult ophthalmic diseases. The annual average number of patients with eye diseases coming to our hospital for treatment from more than 30 provinces and cities all over China is more than 100,000.
Our hospital is one of the hospitals in China where various types of corneal transplantation, phacoemulsification combined with intraocular lens implantation, glaucoma surgery, fundus surgery and laser myoporthosis are early performed. More than 10,000 cases of various types of surgeries have been completed annually. The relevant technologies have reached a leading level in the country and an advanced level internationally.
Characteristics and Speciality
Corneal disease subspecialty: Our hospital is a leading unit in the diagnosis, treatment and scientific research of corneal disease in China, and is also one of the most important corneal transplantation centers in China. One of our experts has long served as the leader of the Corneal Disease Group of Ophthalmological Society of Chinese Medical Association (the group representing the highest academic level in corneal diseases in China). With the outstanding experts, technological superiority and innovation ability in various acid, alkali and thermal burns around eyes, corneal infections caused by fungi, bacteria, viruses and acanthamoeba, and difficult corneal diseases including keratoconus, femtosecond laser-assisted corneal surgeries and endothelium transplantation, supported by the largest provincial red cross eye bank in our country (also the first batch of international cooperation eye bank in China), our hospital provides more than a thousand corneal materials for clinical use annually and relieves the pain for more than 20,000 patients with complicated corneal diseases from all over the country every year. Our hospital has completed more than 1,000 various corneal transplantation surgeries, accounting for 20% of the total corneal transplantation surgeries in China.
Cataract and retina subspecialties: Our hospital performs various kinds of difficult cataract surgeries all year round, especially the high-risk cataract surgeries for opaque corneas and corneas with low endothelial cells counts. Our hospital has initiated cataract extraction combined with 25G pars plana vitrectomy for children with cataract, which is now considered as the most effective surgical treatment, with the lowest risks, for children with congenital cataract in ophthalmology in China. Our diagnosis and treatment for age-related macular degeneration, early, middle and late stages of diabetic retinopathy, various types of retinal detachments, various eye traumas and intraocular infections involving the posterior segment, fundus hemorrhage resulting from various causes and retinopathy of prematurity are leading in China. In the treatment of diabetic retinopathy with laser and surgery, surgical treatment of various difficult retinal detachments, severe eye traumas and intraocular infections, our hospital has outstanding advantages in China. Relying on the incomparable strong technical strength in the field of corneal diseases, our hospital is one of the few medical institutions in China that can perform the major surgery of the eye (corneal transplantation combined with vitrectomy for the treatment of complex ocular trauma and other anterior and posterior segment combined surgeries) and can complete various types of individualized myopia and astigmatism correction surgeries using the femtosecond laser.
Scientific Research Achievements
Since 2011, our hospital has received more than 60 national level and provincial level project funds, more than 25 million yuan for scientific research in total. With the innovations in corneal and ocular surface surgeries, our hospital has won two Second Prize in the National Science and Technology Progress Award and more than ten provincial-level awards including a First Prize in the Shandong Science and Technology Progress Award, ranking top five in China and the first in Shandong province.
Our doctors have published more than 300 academic papers, 133 of which are included in SCI, including PNAS (IF: 9.809), Diabetes (IF:8.474) and so on. 12 papers were published in Ophthalmology, the world’s number one academic journal in ophthalmology.
Our experts have published the only series of monographs on keratopathy in China, including 5 monographs: Cornea, Corneal Transplantation, Corneal Atlas, Clinical Cornea, Surgery of the Cornea and have jointly published 15 teaching CDs and translations such as Collection of Outstanding Corneal Transplant Surgeries, Surgical Treatment of Congenital Cataract, Common Ocular Surface Surgeries and Routine Examination Techniques of Anterior Segment with Chinese Medical Association and People's Medical Publishing House.
Public Interest Activities
Our hospital implements activities helping and supporting the poor in communities and rural areas all year round and has carried out a cataract relief activity called “Great Love in Qilu” in conjunction with Shandong Branch of Red Cross Society of China, covering the whole province. Over the past 10 years, we have helped more than 500 economically disadvantaged families and reduced and remitted more than 3 million diagnosis, treatment and surgery fees.
In 2009, our hospital jointly established a tissue bank for cornea donation and reception with Shandong Branch of Red Cross Society of China, called Eye Bank of Shandong Red Cross, being responsible for the cornea donation and reception work in the 17 cities of Shandong province and assisting the publicity and voluntary services of cornea donation. Our hospital receives about 200 cases of cornea donations annually in Shandong province, making us the biggest cornea tissue bank in China.
Missions and Objectives
Since the establishment of our hospital, we have carried forward the spirit of “loving my profession”, worked hard, attached great importance to independent innovation, developed the belief of “fighting for healthy vision”, adhered to the patient-centered core idea and people-oriented principle and focused on medical treatment and scientific research. We have also taken full advantage of the talents, technology and facilities and learnt internationally advanced management concepts. All these efforts have helped us win trust from patients at home and abroad. In the future, our hospital will endeavor unremittingly to evolve into a domestically leading and internationally renowned eye institution that can provide good and high-quality services and have noble medical ethics, advanced technology and moderate scale to satisfy the patients.
Leaders of our hospital:
Legal representative: Weiyun SHI
President: Weiyun SHI
Vice president: Hua GAO
Vice president: Ting WANG